Skip to main content
NeuronFeed

C the Signs vs Truveta

Which Healthcare AI tool is better in 2026?

C the Signs

$8M

Truveta

$515M

Side-by-side

Verdict

Truveta is the more established option (raised $515M); pricing is comparable on both sides.

Metric C the Signs Truveta
Taglinei
Foundedi 2020🏆
HQi
Employeesi 11-50 11-50
Neuron scorei 61 75🏆
Total fundingi $8M $515M🏆
Latest roundi Venture Series C · Jan 2025
Valuationi $1B🏆
Cheapest paid plani Pricing not disclosed Pricing not disclosed
Free plani
Free triali
Top tier pricei Pricing not disclosed Pricing not disclosed
Pricing summaryi Free Free
Categoriesi

Capability matrix

Developer-facing capabilities and access signals for C the Signs and Truveta.

Capability C the Signs Truveta
MCP support
Public API
Webhooks
OAuth 2.0
SDK languages
Free plan
Free trial
Verified
Active deal

🟢 Strengths of C the Signs

  • Strong in AI Healthcare

🔵 Strengths of Truveta

  • Has raised more capital ($515M vs $8M)
  • Higher Neuron score (75 vs 61)
  • Newer company (2020)

Which should you choose?

Choose Truveta if price matters most — it starts at Free, which is friendlier for teams watching burn. Both AI Healthcare tools ship core features, so the cost delta often decides it for small teams and solo operators.

Choose Truveta if you want the most established option — it has raised $515M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.

Frequently asked questions

C the Signs vs Truveta — which is better?

It depends on your priority. C the Signs is the leaner option; Truveta has broader feature depth. See the side-by-side table above.

Is C the Signs cheaper than Truveta?

No — Truveta's cheapest paid plan is Free, while C the Signs's is Free.

Do C the Signs and Truveta offer free plans?

C the Signs: Yes, has a free plan. Truveta: Yes, has a free plan.

Contextual paths to related AI startups, deals and rankings.